Peter G. Tombros is Director at NPS PHARMACEUTICALS INC (NPSP). They have made 4 open-market trades across 3 companies since 2005, most recently 2017-04-27.
CIK 0001007933
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $88K since 2005, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBM | SELL | 2015-12-11 | 2015-12-15 | $51.37 | $1.6M | -9.8% | -6.3% | -8.3% |
| CBM | SELL | 2014-02-13 | 2014-02-18 | $20.87 | $28K | -9.8% | -1.7% | -1.7% |
| NPSP | SELL · 10b5-1 | 2013-02-07 | 2013-02-11 | $8.74 | $53K | N/A | N/A | N/A |
| NPSP | BUY | 2007-11-16 | 2007-11-20 | $4.34 | $43K | N/A | N/A | N/A |
| PRTX.OB | BUY | 2005-12-30 | 2006-01-04 | $2.25 | $45K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.